T1	CHEM 39 50	bupivacaína
#1	AnnotatorNotes T1	C0006400; bupivacaine; Organic Chemical · Pharmacologic Substance
T2	PROC 54 86	infusión continua para vertebral
T3	PROC 92 113	tratamiento del dolor
#2	AnnotatorNotes T3	C1304888; Pain control; Therapeutic or Preventive Procedure
T4	PROC 117 128	toracotomía
#3	AnnotatorNotes T4	C0039991; Thoracotomy; Therapeutic or Preventive Procedure
T5	PROC 133 151	resección pulmonar
#4	AnnotatorNotes T5	C0396565; Lung excision; Therapeutic or Preventive Procedure
T6	ANAT 143 151	pulmonar
#5	AnnotatorNotes T6	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T7	PROC 372 392	comparar la eficacia
#6	AnnotatorNotes T7	C1707887; Efficacy Study; Research Activity
T8	PROC 311 338	analgesia regional continua
T9	PROC 925 975	se analizaron sobre la base de intención de tratar
#7	AnnotatorNotes T9	C2718028; Intention to Treat Analysis; Research Activity
T10	CHEM 430 441	bupivacaína
#8	AnnotatorNotes T10	C0006400; bupivacaine; Organic Chemical · Pharmacologic Substance
T11	CHEM 511 520	fentanilo
#9	AnnotatorNotes T11	C0015846; Fentanyl; Organic Chemical · Pharmacologic Substance
T12	PROC 674 692	resección pulmonar
#10	AnnotatorNotes T12	C0396565; Lung excision; Therapeutic or Preventive Procedure
T13	ANAT 684 692	pulmonar
#11	AnnotatorNotes T13	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T14	PROC 697 708	toracotomía
#12	AnnotatorNotes T14	C0039991; Thoracotomy; Therapeutic or Preventive Procedure
T15	PROC 843 866	intervención quirúrgica
#13	AnnotatorNotes T15	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T16	PHYS 1390 1419	percepción subjetiva de dolor
#14	AnnotatorNotes T16	C3714605; Pain Perception; Organism Function
T17	PROC 1421 1424	VAS
#15	AnnotatorNotes T17	C0042815; Visual Analog Pain Scale; Diagnostic Procedure
T18	PROC 1343 1359	función pulmonar
#16	AnnotatorNotes T18	C0024119; Pulmonary function tests; Diagnostic Procedure
T19	ANAT 1351 1359	pulmonar
#17	AnnotatorNotes T19	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T20	CHEM 1452 1459	morfina
#18	AnnotatorNotes T20	C0026549; morphine; Organic Chemical · Pharmacologic Substance
T21	DISO 1517 1533	efectos adversos
#19	AnnotatorNotes T21	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T22	PROC 1693 1732	bloqueo paravertebral torácico continuo
T23	ANAT 1715 1723	torácico
#20	AnnotatorNotes T23	C0817096; Chest; Body Location or Region | C1269614; Entire thorax; Body Part, Organ, or Organ Component
T24	DISO 1790 1810	dolor postoperatorio
#21	AnnotatorNotes T24	C0030201; Pain, Postoperative; Sign or Symptom
T25	PROC 1825 1843	resección pulmonar
#22	AnnotatorNotes T25	C0396565; Lung excision; Therapeutic or Preventive Procedure
T26	ANAT 1835 1843	pulmonar
#23	AnnotatorNotes T26	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T27	PROC 1848 1859	toracotomía
#24	AnnotatorNotes T27	C0039991; Thoracotomy; Therapeutic or Preventive Procedure
T28	CHEM 1905 1916	bupivacaína
#25	AnnotatorNotes T28	C0006400; bupivacaine; Organic Chemical · Pharmacologic Substance
T29	PROC 1942 1959	control del dolor
#26	AnnotatorNotes T29	C1304888; Pain control; Therapeutic or Preventive Procedure
T30	DISO 1992 2006	complicaciones
#27	AnnotatorNotes T30	C0009566; Complication; Pathologic Function
T31	CHEM 2049 2060	bupivacaína
#28	AnnotatorNotes T31	C0006400; bupivacaine; Organic Chemical · Pharmacologic Substance
T32	DISO 108 113	dolor
#29	AnnotatorNotes T32	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T33	PROC 153 192	ensayo clínico aleatorizado doble ciego
#30	AnnotatorNotes T33	C0013072; Double-Blind Method; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T34	DISO 235 257	dolor post-toracotomía
#31	AnnotatorNotes T34	C1719391; Post-thoracotomy pain NOS; Sign or Symptom
T35	PROC 567 607	ensayo clínico aleatorizado, doble ciego
#32	AnnotatorNotes T35	C0013072; Double-Blind Method; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T36	DISO 1414 1419	dolor
#33	AnnotatorNotes T36	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T37	CHEM 1884 1903	anestésicos locales
#34	AnnotatorNotes T37	C0002934; Local Anesthetics; Organic Chemical · Pharmacologic Substance
T38	DISO 1954 1959	dolor
#35	AnnotatorNotes T38	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T39	Route 54 62	infusión
#36	AnnotatorNotes T39	C1621368; Intravenous Drip Route of Administration; Functional Concept
T40	DEVI 471 478	catéter
#37	AnnotatorNotes T40	C0085590; catheter device; Medical Device
T41	Route 479 492	paravertebral
#38	AnnotatorNotes T41	C1882285; Paravertebral Route of Administration; Functional Concept
T42	Dose 521 529	2 mcg/ml
T43	LIVB 652 661	pacientes
#39	AnnotatorNotes T43	C0030705; Patients; Patient or Disabled Group
T44	Date 753 770	noviembre de 2010
T45	Date 773 785	mayo de 2011
T46	DEVI 799 806	catéter
#40	AnnotatorNotes T46	C0085590; catheter device; Medical Device
T47	Route 807 820	paravertebral
#41	AnnotatorNotes T47	C1882285; Paravertebral Route of Administration; Functional Concept
T48	LIVB 875 883	paciente
#42	AnnotatorNotes T48	C0030705; Patients; Patient or Disabled Group
T51	Date 1360 1374	postoperatoria
#43	AnnotatorNotes T51	C0032790; Postoperative Period; Temporal Concept
T53	LIVB 1539 1548	pacientes
#44	AnnotatorNotes T53	C0030705; Patients; Patient or Disabled Group
T54	LIVB 1578 1587	pacientes
#45	AnnotatorNotes T54	C0030705; Patients; Patient or Disabled Group
T56	Route 1701 1714	paravertebral
#46	AnnotatorNotes T56	C1882285; Paravertebral Route of Administration; Functional Concept
T57	Duration 1741 1749	48 horas
T58	Date 1796 1810	postoperatorio
#47	AnnotatorNotes T58	C0032790; Postoperative Period; Temporal Concept
T59	Dose 2061 2067	0,30 %
T61	PROC 246 257	toracotomía
#48	AnnotatorNotes T61	C0039991; Thoracotomy; Therapeutic or Preventive Procedure
T62	Dose 443 446	0,2
T49	Dose 1917 1923	0,20 %
T50	Dose 1865 1880	dosis moderadas
T52	Neg_cue 1275 1277	No
T55	CONC 1293 1304	diferencias
A1	Assertion T55 Negated
#49	AnnotatorNotes T55	C1705241; Delta (difference); Quantitative Concept
R1	Negation Arg1:T52 Arg2:T55	
T63	Neg_cue 1624 1626	no
T64	CONC 1613 1623	diferencia
#50	AnnotatorNotes T64	C1705241; Delta (difference); Quantitative Concept
T65	Quantifier_or_Qualifier 1631 1661	estadísticamente significativa
A2	Assertion T65 Negated
#51	AnnotatorNotes T65	C0237881; Statistical Significance; Quantitative Concept
R2	Negation Arg1:T63 Arg2:T65	
R3	Has_Quantifier_or_Qualifier Arg1:T64 Arg2:T65	
R4	Used_for Arg1:T1 Arg2:T2	
R5	Has_Route_or_Mode Arg1:T1 Arg2:T39	
R7	Causes Arg1:T4 Arg2:T32	
R8	Before Arg1:T4 Arg2:T5	
R9	Location_of Arg1:T6 Arg2:T5	
R10	Causes Arg1:T61 Arg2:T34	
R12	Before Arg1:T2 Arg2:T4	
T66	Dose 449 454	0,3 %
R13	Has_Dose_or_Strength Arg1:T10 Arg2:T62	
R14	Has_Dose_or_Strength Arg1:T10 Arg2:T66	
R15	Combined_with Arg1:T10 Arg2:T11	
R16	Has_Dose_or_Strength Arg1:T11 Arg2:T42	
R17	Has_Route_or_Mode Arg1:T10 Arg2:T41	
R18	Used_for Arg1:T40 Arg2:T10	
R19	Experiences Arg1:T43 Arg2:T12	
R20	Experiences Arg1:T43 Arg2:T14	
R21	Location_of Arg1:T13 Arg2:T12	
R22	Before Arg1:T14 Arg2:T12	
R23	After Arg1:T35 Arg2:T44	
R24	Before Arg1:T35 Arg2:T45	
R25	After Arg1:T12 Arg2:T44	
R26	Before Arg1:T12 Arg2:T45	
R27	After Arg1:T14 Arg2:T44	
R28	Before Arg1:T14 Arg2:T45	
R29	Experiences Arg1:T48 Arg2:T15	
T67	Observation 884 893	despierto
#52	AnnotatorNotes T67	C0234422; Awake (finding); Finding
R30	Has_Quantifier_or_Qualifier Arg1:T48 Arg2:T67	
R31	Before Arg1:T46 Arg2:T15	
T68	Observation 894 913	en posición sentada
#53	AnnotatorNotes T68	C0277814; Sitting position; Finding
R32	Has_Quantifier_or_Qualifier Arg1:T48 Arg2:T68	
R33	Before Arg1:T67 Arg2:T15	
R34	Before Arg1:T68 Arg2:T15	
T69	CONC 991 1013	prueba de Chi cuadrado
#54	AnnotatorNotes T69	C0008041; Chi-Square Test; Intellectual Product
T70	CONC 1047 1059	t de Student
#55	AnnotatorNotes T70	C0871453; Students T Test; Intellectual Product
T71	CONC 1073 1094	Mann-Whitney-Wilcoxon
#56	AnnotatorNotes T71	C1708930; Mann-Whitney Test; Intellectual Product
T72	Quantifier_or_Qualifier 1305 1336	estadísticamente significativas
A3	Assertion T72 Negated
R35	Has_Quantifier_or_Qualifier Arg1:T55 Arg2:T72	
#57	AnnotatorNotes T72	C0237881; Statistical Significance; Quantitative Concept
R36	Negation Arg1:T52 Arg2:T72	
R37	Location_of Arg1:T19 Arg2:T18	
R38	Overlap Arg1:T18 Arg2:T51	
T73	Quantifier_or_Qualifier 1460 1469	acumulada
R41	Experiences Arg1:T53 Arg2:T21	
R42	Experiences Arg1:T54 Arg2:T21	
R43	Has_Route_or_Mode Arg1:T22 Arg2:T56	
R44	Location_of Arg1:T23 Arg2:T22	
R45	Has_Duration_or_Interval Arg1:T22 Arg2:T57	
R47	Overlap Arg1:T24 Arg2:T58	
R48	Overlap Arg1:T16 Arg2:T51	
R49	Overlap Arg1:T17 Arg2:T51	
R50	Overlap Arg1:T36 Arg2:T51	
R52	Overlap Arg1:T20 Arg2:T51	
R54	After Arg1:T24 Arg2:T25	
R55	Location_of Arg1:T26 Arg2:T25	
R56	Before Arg1:T27 Arg2:T25	
R57	Causes Arg1:T24 Arg2:T27	
R58	Has_Dose_or_Strength Arg1:T37 Arg2:T50	
R59	Has_Dose_or_Strength Arg1:T28 Arg2:T49	
R60	Used_for Arg1:T37 Arg2:T29	
R61	Used_for Arg1:T28 Arg2:T29	
R63	Overlap Arg1:T38 Arg2:T30	
T74	Quantifier_or_Qualifier 2007 2017	sistémicas
#58	AnnotatorNotes T74	C0205373; Systemic; Functional Concept
R64	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T74	
R65	Causes Arg1:T37 Arg2:T30	
R66	Causes Arg1:T28 Arg2:T30	
R68	Has_Dose_or_Strength Arg1:T31 Arg2:T59	
R69	Causes Arg1:T31 Arg2:T30	
R71	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T73	
R51	Experiences Arg1:T48 Arg2:T46	
#59	AnnotatorNotes T73	C1511559; Cumulative; Qualitative Concept
A4	Experiencer T43 Patient
A5	Experiencer T48 Patient
A6	Experiencer T53 Patient
A7	Experiencer T54 Patient
